Clinical Research Clinical Supply Marketing 
The Pharma Data
SEPTEMBER 15, 2020
Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk.
PPD
SEPTEMBER 6, 2023
Approaches to outsourcing clinical trials have changed significantly in recent years. Mixing of service models — a strategy that drug developers are leveraging now more than ever — can bring life-changing therapies to market faster. Growth of the FSP market is steadily increasing.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Alta Sciences
DECEMBER 14, 2023
Clinical Supply Manufacturing Integration with our manufacturing team, ensuring flexibility and adaptability to meet the evolving needs of your studies throughout your drug development program or study. We can manufacture almost every dosage form on the market. Image GettyImages-897885148_pharmacy.jpg Tags Clinical Trials
The Pharma Data
JANUARY 24, 2021
In clinical research, Cepharanthine exhibits multiple pharmacological properties including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is currently focused on advancing the clinical development of Cepharanthine to treat rare cancer diseases.
BioPharma Drive: Drug Pricing
JUNE 9, 2025
As a gastroenterologist for 35 years, with 25 of those spent in clinical research and seven at Altasciences , I recognize that GLP-1s may be one of the most significant medical advancements of our time—a treatment poised to redefine metabolic disease management. While some insurers are expanding coverage, it remains inconsistent.
PPD
FEBRUARY 3, 2025
In todays clinical research landscape, it is both essential and challenging to accelerate clinical trials. Beyond this, developers face an estimated $500,000 per day in lost potential revenue as drugs are held back from entering the market, underscoring the high stakes of efficiency in drug development.
Drug Target Review
MAY 27, 2025
With a background in molecular biology and cancer research, she has played a pivotal role in advancing more than 100 clinical trials during her time at BeOne and has helped bring over 25 compounds to market. She has managed a portfolio of ~1,500 clinical trials a year.
Expert insights. Personalized for you.
52 
Let's personalize your content